Black Diamond Therapeutics to Present at Morgan Stanley 18th Annual Global Healthcare Conference
CAMBRIDGE, Mass. and NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update about the Company’s progress at the Morgan Stanley 18th Annual Global Healthcare Conference. The presentation will take place on Tuesday, September 15, 2020, at 2:45 PM ET.
A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, www.blackdiamondtherapeutics.com. A replay of the presentation will also be available and archived on the site for three weeks.
Abou Black Diamond
IoT Transportation Solutions for Government Agencies
Autonomation and Predictability in IIoT